These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 23327868)
1. [Expressions and significances of CRABPII and E-FABP in non-small cell lung cancer]. Liu Q; Wang S; Xu H; Zhang S Zhongguo Fei Ai Za Zhi; 2013 Jan; 16(1):12-9. PubMed ID: 23327868 [TBL] [Abstract][Full Text] [Related]
2. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer]. Li J; Tu Y; Jiang L; Xu H; Zhang S Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682 [TBL] [Abstract][Full Text] [Related]
3. The expression of p33(ING1), p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Liu J; Lin Y; Yang H; Deng Q; Chen G; He J Tumour Biol; 2011 Dec; 32(6):1113-21. PubMed ID: 21779982 [TBL] [Abstract][Full Text] [Related]
4. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer]. Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277 [TBL] [Abstract][Full Text] [Related]
5. [Expression of alpha-tubulin and MDR1 and their correlation with the biological features of non-small cell lung carcinoma]. Chen QY; Jiang ZY; Wu LJ; Zhang BY; Lu GH; Zhou JY Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):278-82. PubMed ID: 20510079 [TBL] [Abstract][Full Text] [Related]
6. Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis. Zhang S; Wang Y; Dai SD; Wang EH BMC Cancer; 2011 May; 11():186. PubMed ID: 21599923 [TBL] [Abstract][Full Text] [Related]
7. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers. Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877 [TBL] [Abstract][Full Text] [Related]
8. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer. Gao Q; Yang S; Kang MQ Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832 [TBL] [Abstract][Full Text] [Related]
9. [Expressions of APC and c-Myc and its implication on non-small cell lung cancer]. Wang SF; Liu Q; Zhang SF; Liao DY; Xu H; Zhang WY; Li WM; Liu LX Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):822-6. PubMed ID: 21302450 [TBL] [Abstract][Full Text] [Related]
10. Increased high-mobility group A2 correlates with lymph node metastasis and prognosis of non-small cell lung cancer. Guo X; Shi J; Wen Y; Li M; Li Q; Li X; Li J Cancer Biomark; 2018 Feb; 21(3):547-555. PubMed ID: 29278873 [TBL] [Abstract][Full Text] [Related]
11. New P16 Expression Criteria Predict Lymph Node Metastasis in Patients With Non-small Cell Lung Cancer. An HJ; Koh HM; Song DH In Vivo; 2019; 33(6):1885-1892. PubMed ID: 31662516 [TBL] [Abstract][Full Text] [Related]
12. [Expressions of Nm23, E-cadherin, and beta-catenin in non-small cell lung cancer and their correlations with metastasis and prognosis]. Tang XJ; Zhou QH; Zhang SF; Liu LX Ai Zheng; 2005 May; 24(5):616-21. PubMed ID: 15890109 [TBL] [Abstract][Full Text] [Related]
13. [Expression and significance of MIF and CD147 in non-small cell lung cancer]. Liu Q; Yang H; Zhang SF Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):85-90. PubMed ID: 20369477 [TBL] [Abstract][Full Text] [Related]
14. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis]. Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445 [TBL] [Abstract][Full Text] [Related]
15. Elevated expression of FABP3 and FABP4 cooperatively correlates with poor prognosis in non-small cell lung cancer (NSCLC). Tang Z; Shen Q; Xie H; Zhou X; Li J; Feng J; Liu H; Wang W; Zhang S; Ni S Oncotarget; 2016 Jul; 7(29):46253-46262. PubMed ID: 27323829 [TBL] [Abstract][Full Text] [Related]
16. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related]
17. Novel long non-coding RNA LBX2-AS1 indicates poor prognosis and promotes cell proliferation and metastasis through Notch signaling in non-small cell lung cancer. Tang LX; Su SF; Wan Q; He P; Xhang Y; Cheng XM Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7419-7429. PubMed ID: 31539129 [TBL] [Abstract][Full Text] [Related]
18. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer. Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249 [TBL] [Abstract][Full Text] [Related]
19. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)]. Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482 [TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of PTEN/PI3K signal transduction-related proteins in non-small cell lung cancer]. Liao DW; Wang L; Zhang XG; Liu MQ Ai Zheng; 2006 Oct; 25(10):1238-42. PubMed ID: 17059767 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]